Skip to main content
Dana-Farber
  • person
  • dana-farber.org
  • Search
  • Featured Specialties
    • Breast Oncology
    • Gastrointestinal Oncology
    • Genitourinary Oncology
    • Gynecologic Oncology
    • Hematologic Oncology
    • Pediatric Oncology
  • Find a Physician
  • Find a Clinical Trial
  • Refer a Patient
  • Contact Us

Sara Tolaney, MD, MPH

Medical Oncology

Sara Tolaney, MD, MPH

View full profile


Related Videos

ASCENT-03 Study Presented by Sara Tolaney, MD, MPH Video

ASCENT-03 Study Presented by Sara Tolaney, MD, MPH

Dr. Sara Tolaney details research in The New England Journal of Medicine showing the ADC sacituzumab govitecan improved outcomes for patients with advanced triple-negative #BreastCancer ineligible for immune checkpoint inhibitors.

ASCO 2023: Breast Cancer Research Presented by Sara Tolaney, MD Video

ASCO 2023: Breast Cancer Research Presented by Sara Tolaney, MD

Data shows antibody-drug conjugate offers significant survival benefit for patients with HR-positive/HER2-negative metastatic breast cancer.

Welcome Session | 2022-2023 EMBRACE MBC Virtual Forum Series Video

Welcome Session | 2022-2023 EMBRACE MBC Virtual Forum Series

Nancy Lin, MD; Sara Tolaney, MD, MPH; and patient advocate Lianne Kraemer discuss new developments and promising areas of research in metastatic breast cancer at Dana-Farber and beyond.

Connect with us

Facebook_DanaFarber_Blue_icon X_DanaFarber_Blue_icon Instagram_DanaFarber_Blue_icon Youtube_DanaFarber_Blue_icon LinkedIn_DanaFarber_Blue_icon
  • About Us
  • Research
  • Medical Oncology Spotlight
  • Transfer a Patient
  • Find a Physician
  • Refer a Patient
  • Clinical Resources
  • Dana-Farber
Powered by BroadcastMedBROADCASTMED